Additionally, blocking IFN-γ in mice who received anti-CTLA-4 therapy also suppressed the induction of IDO in the tumor microenvironment, suggesting that the effector mechanism of immune checkpoint blockade may be mediated by IFN-γ [32]. The gene discussed is IDO1; the disease is neoplasm.